At the pace with which the proportion of overweight people is growing, half of Nepal’s adult population will be obese by 2050 ...

When you or your bed partner has sleep apnea, a restful night’s sleep can be hard to come by. Treating this common condition ...

The new craze of using lower-than-recommended dosages of weight loss drugs to slim down might sound tempting, says Charlotte ...

Compounded GLP-1s have given rise to a cottage industry offering cheaper weight loss medications to many Americans — but now ...

Food addiction is considered a behavioral addiction, similar to gambling. Learn to recognize the traits and where to get help.

After years of weight loss drug shortages, the FDA is saying there’s now an adequate supply for most medications and they ...

Altimmune said on Thursday that it plans to test its lead experimental obesity drug, pemvidutide, to potentially treat ...

Mehmet Oz will likely face questions during his confirmation hearing about his past support of expanding the Medicare ...

Highmark cited exorbitant drug costs, higher medical utilization and sicker patients remaining in its Medicaid business for fueling fiscal pressures.

Viking Therapeutics eyes billion-dollar obesity drug markets with pivotal trials and major production deals. Read more about ...

To the person who continues to comment about our bad experience at the Plant City Strawberry Festival, you didn’t pay $85 for ...

Roche is doubling down on competing for a slice of the rapidly growing GLP-1 pie. The Swiss pharma giant announced a deal worth up to $5.3 billion on Wednesday with Danish drugmaker Zealand Pharma to ...